Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease
Status:
Completed
Trial end date:
1998-12-01
Target enrollment:
Participant gender:
Summary
A clinical trial to assess safety and two regimens of (MEDI-507) a drug given to stem cell
and bone marrow recipients who have a mid-grade acute Graft-versus-Host Disease.